These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 30977107)
41. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response. Sakamoto K; Katayama R; Asaka R; Sakata S; Baba S; Nakasone H; Koike S; Tsuyama N; Dobashi A; Sasaki M; Ichinohasama R; Takakuwa E; Yamazaki R; Takizawa J; Maeda T; Narita M; Izutsu K; Kanda Y; Ohshima K; Takeuchi K Leukemia; 2018 Dec; 32(12):2590-2603. PubMed ID: 29795241 [TBL] [Abstract][Full Text] [Related]
42. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm. Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387 [TBL] [Abstract][Full Text] [Related]
43. Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin. Batta K; Bossenbroek HM; Pemmaraju N; Wilks DP; Chasty R; Dennis M; Milne P; Collin M; Beird HC; Taylor J; Patnaik MM; Cargo CA; Somervaille TCP; Wiseman DH Leukemia; 2021 Nov; 35(11):3299-3303. PubMed ID: 33833384 [No Abstract] [Full Text] [Related]
44. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes. Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808 [TBL] [Abstract][Full Text] [Related]
45. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas. Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329 [TBL] [Abstract][Full Text] [Related]
46. Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report. Luo F; Li B; Li J; Li Y Oncol Lett; 2024 May; 27(5):220. PubMed ID: 38586204 [TBL] [Abstract][Full Text] [Related]
47. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity. Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315 [TBL] [Abstract][Full Text] [Related]
48. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. Bausch B; Borozdin W; Mautner VF; Hoffmann MM; Boehm D; Robledo M; Cascon A; Harenberg T; Schiavi F; Pawlu C; Peczkowska M; Letizia C; Calvieri S; Arnaldi G; Klingenberg-Noftz RD; Reisch N; Fassina A; Brunaud L; Walter MA; Mannelli M; MacGregor G; Palazzo FF; Barontini M; Walz MK; Kremens B; Brabant G; Pfäffle R; Koschker AC; Lohoefner F; Mohaupt M; Gimm O; Jarzab B; McWhinney SR; Opocher G; Januszewicz A; Kohlhase J; Eng C; Neumann HP; J Clin Endocrinol Metab; 2007 Jul; 92(7):2784-92. PubMed ID: 17426081 [TBL] [Abstract][Full Text] [Related]
49. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Ricciardone MD; Ozçelik T; Cevher B; Ozdağ H; Tuncer M; Gürgey A; Uzunalimoğlu O; Cetinkaya H; Tanyeli A; Erken E; Oztürk M Cancer Res; 1999 Jan; 59(2):290-3. PubMed ID: 9927033 [TBL] [Abstract][Full Text] [Related]
50. Clinical presentation and genetic analyses of neurofibromatosis type 1 in independent patients with monoallelic double de novo closely spaced mutations in the NF1 gene. Stella A; Lastella P; Viggiano L; Bagnulo R; Resta N Hum Mutat; 2022 Oct; 43(10):1354-1360. PubMed ID: 35723633 [TBL] [Abstract][Full Text] [Related]
54. Blastic Plasmacytoid Dendritic Cell Neoplasm Evaluated by FDG PET/CT. Li ZG; Mu HY Clin Nucl Med; 2017 Jul; 42(7):551-552. PubMed ID: 28394841 [TBL] [Abstract][Full Text] [Related]
55. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face]. Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094 [TBL] [Abstract][Full Text] [Related]
56. Germline mutation of CHEK2 in neurofibromatosis 1 and 2: Two case reports. Li Q; Zhao F; Ju Y Medicine (Baltimore); 2018 Jun; 97(23):e10894. PubMed ID: 29879026 [TBL] [Abstract][Full Text] [Related]
57. Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1. Monroe CL; Dahiya S; Gutmann DH Annu Rev Pathol; 2017 Jan; 12():53-74. PubMed ID: 28135565 [TBL] [Abstract][Full Text] [Related]
58. A search for evidence of somatic mutations in the NF1 gene. John AM; Ruggieri M; Ferner R; Upadhyaya M J Med Genet; 2000 Jan; 37(1):44-9. PubMed ID: 10633134 [TBL] [Abstract][Full Text] [Related]
59. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease. Abramowicz A; Gos M Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393 [TBL] [Abstract][Full Text] [Related]
60. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events. Tang Z; Li Y; Wang W; Yin CC; Tang G; Aung PP; Hu S; Lu X; Toruner GA; Medeiros LJ; Khoury JD Leuk Res; 2018 Oct; 73():86-94. PubMed ID: 30248580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]